C07C211/00

Fullerene derivatives and organic electronic device comprising fullerene derivatives

The present specification relates to an organic electronic device including a fullerene derivative.

Fullerene derivatives and organic electronic device comprising fullerene derivatives

The present specification relates to an organic electronic device including a fullerene derivative.

Hydrogel materials incorporating eluting ceragenin compound
10676501 · 2020-06-09 · ·

A hydrogel polymer includes a ceragenin compound. The ceragenin compound has a hydrophobicity/hydrophilicity that produces a release rate in a range of 0.1-100 g/ml for at least 3 days.

Hydrogel materials incorporating eluting ceragenin compound
10676501 · 2020-06-09 · ·

A hydrogel polymer includes a ceragenin compound. The ceragenin compound has a hydrophobicity/hydrophilicity that produces a release rate in a range of 0.1-100 g/ml for at least 3 days.

Halogen-free electrolytes for magnesium batteries

An electrochemical cell includes a high voltage cathode configured to operate at 1.5 volts or greater, an anode including Mg.sup.0, and an electrolyte including an at least one organic solvent, at least one magnesium salt, and at least one additive agent including a Lewis base, wherein the electrolyte is halogen-free.

Halogen-free electrolytes for magnesium batteries

An electrochemical cell includes a high voltage cathode configured to operate at 1.5 volts or greater, an anode including Mg.sup.0, and an electrolyte including an at least one organic solvent, at least one magnesium salt, and at least one additive agent including a Lewis base, wherein the electrolyte is halogen-free.

Liquid-organic hydrogen carrier systems based on catalytic peptide formation and hydrogenation

The present invention provides a system and method of storing hydrogen (H.sub.2) and releasing it on demand, comprising and making use of diaminoalkanes and alcohols, or aminoalcohols as liquid-organic hydrogen carrier systems (LOHC). 2-amino-ethanol (AE) or its N-methyl derivative 2-(methylamino)ethanol undergo catalytic dehydrogenation to form a cyclic dipeptide (glycine anhydrideGA) or its N,N-dimethyl derivative (N,N-dimethyl GA) with release of hydrogen. Similarly, ethylenediamine (ED) and ethanol undergo catalytic dehydrogenation to form N,N-diacetylethylenediamine (DAE) with release of hydrogen. Glycine anhydride (GA) or N,N-dimethyl-GA may be hydrogenated back to 2-aminoethanol (AE) or 2-(methylamino)ethanol, respectively, each of which functions as a hydrogen storage system. N,N-diacetylethylenediamine (DAE) may be hydrogenated back to ED and ethanol, which functions as a hydrogen storage system. These reactions may be catalyzed by a variety of compounds or complexes, including Ruthenium complexes as described herein.

Liquid-organic hydrogen carrier systems based on catalytic peptide formation and hydrogenation

The present invention provides a system and method of storing hydrogen (H.sub.2) and releasing it on demand, comprising and making use of diaminoalkanes and alcohols, or aminoalcohols as liquid-organic hydrogen carrier systems (LOHC). 2-amino-ethanol (AE) or its N-methyl derivative 2-(methylamino)ethanol undergo catalytic dehydrogenation to form a cyclic dipeptide (glycine anhydrideGA) or its N,N-dimethyl derivative (N,N-dimethyl GA) with release of hydrogen. Similarly, ethylenediamine (ED) and ethanol undergo catalytic dehydrogenation to form N,N-diacetylethylenediamine (DAE) with release of hydrogen. Glycine anhydride (GA) or N,N-dimethyl-GA may be hydrogenated back to 2-aminoethanol (AE) or 2-(methylamino)ethanol, respectively, each of which functions as a hydrogen storage system. N,N-diacetylethylenediamine (DAE) may be hydrogenated back to ED and ethanol, which functions as a hydrogen storage system. These reactions may be catalyzed by a variety of compounds or complexes, including Ruthenium complexes as described herein.

Bacterial efflux pump inhibitors

Disclosed herein are compounds of formula I: and salts thereof. Also disclosed are compositions comprising compounds of formula I and methods using compounds of formula I. ##STR00001##

Bacterial efflux pump inhibitors

Disclosed herein are compounds of formula I: and salts thereof. Also disclosed are compositions comprising compounds of formula I and methods using compounds of formula I. ##STR00001##